Skip to main content
Premium Trial:

Request an Annual Quote

Deltadot Raises $6M Private Equity for R&D, Marketing

NEW YORK (GenomeWeb News) - Deltadot said today it has received £3 million ($6.1 million) to close a round of private equity funding that it will use to support R&D and marketing.
The company originally announced the funding round in March 2006. The financing announced today is the fourth and final tranche for the round and brings the total funds raised to £6 million ($12.2 million).
The funding was led by Fleming Family & Partners Private Equity, and included investments from Imperial Innovations, NPI Ventures, Sitka Health Fund VCT, and London Technology Fund.
Deltadot’s CEO, Anthony Baxter, said the molecular imaging company will use the capital to ramp up production of its Peregrine high-performance capillary electrophoresis system, to develop capillary and microfluidic technologies such as its Osprey system, and to develop international sales and marketing programs, particularly in the US.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.